Abstract The Washington University School of Medicine Knight Alzheimer Disease Research
Center's “African American Participation in Alzheimer Disease Research: Effective …

Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) research has
advanced gene and biomarker technologies to aid identification of individuals at risk for …

INTRODUCTION: Here we evaluate frequencies of the top 10 Alzheimer's disease (AD) risk
alleles for late‐onset AD in Mexican American (MA) and non‐Hispanic White (NHW) …

Background The Alzheimer's Disease Sequencing Project (ADSP) was announced in
February 2012 by National Institutes of Health (NIH) to sequence the genomes of a large …

Introduction Numerous studies have collected Alzheimer's disease (AD) cohort data sets. To
achieve reproducible, robust results in data‐driven approaches, an evaluation of the present …

Almost every recent Alzheimer's disease (AD) genome-wide association study (GWAS) has
performed meta-analysis to combine studies with clinical diagnosis of AD with studies that …

Introduction Because of its genetic underpinnings and consistent age of onset within
families, autosomal dominant Alzheimer's disease (ADAD) provides a unique opportunity to …

In 1906, Alois Alzheimer, a clinical psychiatrist and neuroanatomist, described “a peculiar
severe disease process of the cerebral cortex” in a 50-year-old woman with paranoia …

Introduction Data are limited for comparison of sex‐and race/ethnicity‐specific risks of
Alzheimer's disease and related dementia (ADRD). Methods In the population‐based …

The genetic architecture of late-onset Alzheimer disease (AD) in African Americans (AAs)
differs from that in persons of European ancestry. In addition to APOE, genome-wide …